医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
21期
66-67
,共2页
李新才%晏平先%邓凤君%曾碧映%肖凌
李新纔%晏平先%鄧鳳君%曾碧映%肖凌
리신재%안평선%산봉군%증벽영%초릉
替米沙坦%吲哒帕胺%高值血压%糖脂代谢
替米沙坦%吲噠帕胺%高值血壓%糖脂代謝
체미사탄%신달파알%고치혈압%당지대사
Telmisartan%Indapamide%High blood pressure%Lipid metabolism
目的:分析替米沙坦与吲哒帕胺对正常高值血压糖脂代谢的影响。方法选取我院2011年11月~2012年10月收治的正常高值血压患者162例,将其随机分为观察组和对照组各81例,观察组给予服用替米沙坦,对照组服用吲哒帕胺,比较两组患者用药后血压及血糖、血脂等生化指标变化情况。结果观察组用药后收缩压、舒张压分别为(125.84±3.02)mmHg、(76.83±4.55)mmHg,与对照组比较无明显差异,>0.05;而TC、TG、HDL-C均高于对照组,两组比较差异显著,差异具有统计学意义,<0.01;且LDL-C显著低于对照组,两组对比差异明显,<0.01;而观察组患者FPG与对照组无统计学差异,>0.05。结论正常高值血压患者服用替米沙坦和吲哒帕胺均可有效降低血压,而替米沙坦可改善患者糖脂代谢,可作为高血压的预防药物在临床应用。
目的:分析替米沙坦與吲噠帕胺對正常高值血壓糖脂代謝的影響。方法選取我院2011年11月~2012年10月收治的正常高值血壓患者162例,將其隨機分為觀察組和對照組各81例,觀察組給予服用替米沙坦,對照組服用吲噠帕胺,比較兩組患者用藥後血壓及血糖、血脂等生化指標變化情況。結果觀察組用藥後收縮壓、舒張壓分彆為(125.84±3.02)mmHg、(76.83±4.55)mmHg,與對照組比較無明顯差異,>0.05;而TC、TG、HDL-C均高于對照組,兩組比較差異顯著,差異具有統計學意義,<0.01;且LDL-C顯著低于對照組,兩組對比差異明顯,<0.01;而觀察組患者FPG與對照組無統計學差異,>0.05。結論正常高值血壓患者服用替米沙坦和吲噠帕胺均可有效降低血壓,而替米沙坦可改善患者糖脂代謝,可作為高血壓的預防藥物在臨床應用。
목적:분석체미사탄여신달파알대정상고치혈압당지대사적영향。방법선취아원2011년11월~2012년10월수치적정상고치혈압환자162례,장기수궤분위관찰조화대조조각81례,관찰조급여복용체미사탄,대조조복용신달파알,비교량조환자용약후혈압급혈당、혈지등생화지표변화정황。결과관찰조용약후수축압、서장압분별위(125.84±3.02)mmHg、(76.83±4.55)mmHg,여대조조비교무명현차이,>0.05;이TC、TG、HDL-C균고우대조조,량조비교차이현저,차이구유통계학의의,<0.01;차LDL-C현저저우대조조,량조대비차이명현,<0.01;이관찰조환자FPG여대조조무통계학차이,>0.05。결론정상고치혈압환자복용체미사탄화신달파알균가유효강저혈압,이체미사탄가개선환자당지대사,가작위고혈압적예방약물재림상응용。
Objective To analyze the telmisartan and YinDaPaAn glucolipid metabolism of blood pressure on the normal high values. Methods From November 2011 to October 2011 treated 162 patients with normal blood pressure high value, its each 81 cases were randomly divided into observation group and control group, observation group was given taking telmisartan, take YinDaPaAn control group, compared two groups of patients after blood pressure and blood sugar, blood lipids and other biochemical index changes. Results Observation group after systolic pressure, diastolic pressure (125.84 +/ - 3.02 mmHg, respectively (76.83 + 4.55) mmHg, compared with the control group no significant dif erence, P>0.05; While the TC, TG, HDL-C were higher than control group, two groups is significant dif erence, the dif erence is statistically significant, <0.01;And LDL-C was significantly lower than the control group, significant dif erence comparing the two groups, <0.01;And the observation group of patients with FPG no statistical dif erence with control group, > 0.05). Conclusion High normal values of blood pressure in patients with telmisartan and YinDaPaAn al can ef ectively reduce the blood pressure, and telmisartan glucolipid metabolism, can improve patients can be used as the prevention of high blood pressure drugs in clinical application.